FP
Flagship Pioneering Portfolio holdings
AUM
$268M
This Quarter Return
+20.01%
1 Year Return
-54.4%
3 Year Return
-51.2%
5 Year Return
+66.7%
10 Year Return
–
AUM
$268M
AUM Growth
+$268M
(+14%)
Cap. Flow
-$244M
Cap. Flow
% of AUM
-90.88%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Seres Therapeutics
MCRB
|
$244M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Moderna
MRNA
$9.37B
| $128M | 47.6% | 4,632,149 | – | – |
|
2
Sana Biotechnology
SANA
$777M
| $68.3M | 25.42% | 25,001,856 | – | – |
|
3
Foghorn Therapeutics
FHTX
$286M
| $59.6M | 22.19% | 12,674,120 | – | – |
|
|
4
Seres Therapeutics
MCRB
$166M
| $12.8M | 4.78% | 1,155,850 -21,961,195 | -95% | -$244M |
|